CH-6370 Stans - Switzerland
T +41 (0)840 200 010
F +41 (0)840 200 011
The Group generated operating revenues of CHF 0.34 million in the half year ending 30 June 2010 (2009: CHF 7.99 million), against operating expenses of CHF 10.3 million (2009: CHF 11.89 million) for the same period. 81% of the operating expenses were derived from research and development activities (2009: 78%).
mondoBIOTECH holding AG announces today the closing of its share capital increase. The Company has raised CHF 7.4 million.
mondoBIOTECH holding AG announce today the availability of its unaudited and not reviewed interim financial information 31 March 2010, which has been prepared for disclosure into the Offering Circular dated 30 July 2010. The Company does normally not disclose quarter financial information.